definiens: means the use of Genome Editing Technology inconnection with the Research, Development, Manufacture, Commercialization orother exploitation of ( a ) α - β T - Cells or ( b ) Other Derived T - Cells ; provided, however, that ( i ) to the extent that, due to the Allergan Agreement, Editas does not have theright to grant rights hereunder to Juno to use Genome Editing Technology on α - β T - Cell or Other Derived T - Cell products specifically intended for the treatment, control, mitigation, prevention or cure of any disease ( excluding cancer ) of the eye or itsadnexa ( the ), then the Licensed Field shall exclude theExcluded Ocular Field and ( ii ) to the extent that, due to the Beam Agreement, Editasdoes not have the right to grant rights hereunder to Juno to use Base Editingtechnology on α - β T - Cell or Other Derived T - Cell products specifically intended forany field outside of cancer ( the ), then theLicensed Field shall exclude the Excluded Base Editing Non - Cancer Field